Beam Therapeutics Inc

BEAM

Equity

ISIN null / Valor 50337226

NASDAQ (2026-03-27)

USD 22.19-6.05%

Beam Therapeutics Inc
UMushroom community rating:

4.00 4 votes No rating yet

NegativeNeutralPositive

About company

Beam Therapeutics Inc is a biotechnology company focused on developing innovative gene editing technologies to treat a wide range of genetic diseases. The company's delivery strategy involves utilizing a suite of clinically validated technologies, including electroporation, nonviral, and viral delivery modalities, to efficiently and precisely edit genes. Beam Therapeutics Inc aims to revolutionize the field of gene editing by providing novel solutions for patients with genetic disorders.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

%1Y

-27.3%3Y

-72.7%5Y

Performance

78.0%1Y

71.0%3Y

76.1%5Y

Volatility

2260 M

Market cap (USD)

2,631,163

Daily traded volume (Shares)

26.41 / 24.77

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

4 votes

Performance:

3.75

Innovation:

3.25

Society:

3.00

Nature:

2.75

Fabio Kull

Switzerland, 30 Oct 2025

promising biotech company focused on precise gene editing. The stock is innovative but risky

Carlos Mayes

United Kingdom, 21 Oct 2025

Strong growth currently

Ben Marshall

United Kingdom, 21 Oct 2025

Currently performing very well however has potential to fall off completely soon

EQUITIES OF THE SAME SECTOR

Softing AG

Softing AG Valor: 1080222

Annual Return

-50%0%+50%

Risk level

110

0.69%EUR 2.92

Embracer Group AB

Embracer Group AB Valor: 113946352

Annual Return

-50%0%+50%

Risk level

110

-0.71%SEK 46.59

MercadoLibre Inc

MercadoLibre Inc Valor: 3109814

Annual Return

-50%0%+50%

Risk level

110

-1.93%USD 1,599.52

Kingsoft Cloud Holdings Ltd

Kingsoft Cloud Holdings Ltd Valor: 54578933

Annual Return

-50%0%+50%

Risk level

110

-5.63%USD 13.59

Synopsys Inc

Synopsys Inc Valor: 975377

Annual Return

-50%0%+50%

Risk level

110

-5.34%USD 380.47

Cognizant Technology Solutions Corp

Cognizant Technology Solutions Corp Valor: 922121

Annual Return

-50%0%+50%

Risk level

110

-1.70%USD 59.73

GLOBALFOUNDRIES INC

GLOBALFOUNDRIES INC Valor: 114166096

Annual Return

-50%0%+50%

Risk level

110

-3.66%USD 42.94

Exelixis Inc

Exelixis Inc Valor: 1069927

Annual Return

-50%0%+50%

Risk level

110

-1.96%USD 41.53

CeoTronics Aktiengesellschaft Audio . Video . Data Communication

CeoTronics Aktiengesellschaft Audio . Video . Data Communication Valor: 942127

Annual Return

-50%0%+50%

Risk level

110

-3.03%EUR 11.20

Alphabet Inc

Alphabet Inc Valor: 29798545

Annual Return

-50%0%+50%

Risk level

110

-2.49%USD 273.76

Logos provided by Clearbit

Beam Therapeutics Inc

BEAM

ISIN null / Valor 50337226

Beam Therapeutics Inc UMushroom community rating:

Fabio Kull

Carlos Mayes

Ben Marshall

Beam Therapeutics Inc
UMushroom community rating: